Latest Rhinitis Stories
OXFORD, England, April 19, 2011 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has closed a GBP60 million ($98 million) fundraising.
Experts at Cincinnati Children's Give Parents Tips on How to Tell the Difference CINCINNATI, March 30, 2011 /PRNewswire-USNewswire/ -- One of the problems that parents may have during the springtime is deciphering whether their children's sneezing is due to a cold or allergies. "Runny, stuffy or itchy noses, sneezing, coughing, fatigue, and headaches can all be symptoms of both allergies and colds but when parents pay close attention to minor details they will be able to tell the...
SAN FRANCISCO, March 21, 2011 /PRNewswire/ -- Results from a recent pivotal allergic rhinitis (AR) satisfaction survey assessing patient and healthcare provider perspectives on AR reveal that symptoms like nasal congestion and post-nasal drip continue to impact patients' daily activities.
SAN FRANCISCO, March 21, 2011 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) agonists and antagonists for the treatment of cancer, respiratory and autoimmune diseases, announced today the presentation of positive clinical results from its randomized, placebo-controlled clinical trial evaluating VTX-1463 for the treatment of allergic rhinitis.
The longer days and warmer weather are not only a sign that spring has sprung, but also a signal that allergies are in full bloom.
Warmer temperatures and later autumn frosts have been the main sources for why the ragweed allergy season in North America has grown two to four weeks longer than usual, according to researchers.
Following a large number of loyal customers coming from the UK and Europe, It is no surprise that SinusWars in keeping with customer satisfaction always guaranteed, has made the crucial move into supplying the international market from a warehouse in the UK.
IRVINE, Calif., Dec. 14, 2010 /PRNewswire/ -- ISTA Pharmaceuticals, Inc.
Immunotherapy given as pills or drops under the tongue is a safe and effective way to treat hayfever-like allergies caused by pollen and dust mites.
OXFORD, England, November 18, 2010 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced successful clinical results from a phase II study of its T-cell vaccine targeting house dust mite allergy.